Dr. Gelovani is the pioneer of molecular-genetic in vivo imaging. His research interests include molecular PET imaging of cancer and the central nervous system using newly developed radiotracers, genomics and proteomics for cancer therapy, adoptive immunotherapy and regenerative stem cell therapies. He holds more than 15 patents, has published more than 160 papers and book chapters, and edited a major book in molecular imaging in oncology. Additionally, several diagnostic imaging compounds he developed are currently in clinical trials in cancer patients.